Atlas Trials

A Clinical Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets

Clinical trial NCT06507891 · TERMINATED

Trial details

NCT number
NCT06507891
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Non Small Cell Lung Cancer
Start date
2020-07-06
Primary completion
2023-08-25
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.